Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms.

Guo, Jinhui; Zhao, Jie; Fu, Wen; Xu, Qiuran; Huang, Dongsheng

Guo, Jinhui; Zhao, Jie; Fu, Wen; Xu, Qiuran; Huang, Dongsheng.

Afiliação

Guo J; Qingdao Medical College, Qingdao University, Qingdao, China.
Zhao J; Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
Fu W; College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China.
Xu Q; Qingdao Medical College, Qingdao University, Qingdao, China.
Huang D; Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.

Front Immunol ; 13: 918314, 2022.

Article em En | MEDLINE | ID: mdl-35935969

Assuntos

Neoplasias; Tioléster Hidrolases; Ubiquitina Tiolesterase/metabolismo; Resistência a Medicamentos; Fatores de Transcrição Forkhead/metabolismo; Humanos; Evasão da Resposta Imune; Masculino; Tioléster Hidrolases/metabolismo

Palavras-chave

DUBs; USP22; cancer; deubiquitination; immune evasion; ubiquitylation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tioléster Hidrolases / Ubiquitina Tiolesterase / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google